80,000 per cent multibagger returns; Board likely to announce bonus shares!

The stock gave multibagger returns of 300 per cent in just 1 year, 4,200 per cent in 5 years and a whopping 80,000 per cent in a decade.

Shukra Pharmaceuticals Ltd inform you that the meeting of the Board of Directors of the company is scheduled to be held on Thursday, February 29, 2024, at the Registered Office of the company inter alia to consider and approve the following:

• To consider and approve the proposal for issuance of fully paid-up bonus equity shares to the members of the company subject to necessary approval.
• To consider and approve the proposal of an increase in the authorized share capital of the company and subsequent alteration to the memorandum of association of the company. if needed, subject to necessary approval.
• To consider and finalize the matters to be included in the notice of EGM/Postal ballot including day, date, place & time, if required.

Today, shares of Shukra Pharmaceuticals Ltd were locked in a 5 per cent upper circuit to Rs 250.40 per share from its previous closing of Rs 238.50. The stock also traded at a new 52-week high of Rs 250.40.  

Established in 1993, Shukra Pharmaceuticals Ltd. operates in both manufacturing and trading pharmaceuticals, alongside offering laboratory testing services. The company has a market cap of over Rs 250 crore with a 3-year stock price CAGR of 200 per cent.

The company reported positive results in both quarterly and annual financial statements. In Q3FY24, net sales rose by 721 per cent to Rs 18.89 crore and net profit skyrocketed 314 times to Rs 9.42 per cent compared to Q3FY23. In FY22, the company did net sales of Rs 20.48 crore and net profit skyrocketed 295 per cent.

According to the shareholding, the promoters own a 50.95 per cent stake in the company while DIIs own 0.11 per cent and the public owns 48.94 per cent as of December 2023. The stock gave multibagger returns of 300 per cent in just 1 year, 4,200 per cent in 5 years and a whopping 80,000 per cent in a decade. Investors should keep an eye on this micro-cap stock.

Disclaimer: The article is for informational purposes only and not investment advice.

For more such updates on the go, Click here to join our WhatsApp Channel